The high cost of biologics is one of the biggest barriers to global healthcare access. Today, biologic therapies are largely confined to developed countries with a GDP per capita of $12,000 or more—leaving billions without access. But what if we could change that?
Join us on February 18, 2025, as Dr. Peng Jiao, Founder & CEO of BiBo, unveils our vision for cutting monoclonal antibody (mAb) production costs from $100/gram to just $10/gram—a game-changer that could expand biologic access to 6 billion more people worldwide.
📅 Date: February 18, 2025
⏰ Time: 11:00 PM (Beijing) | 4:00 PM (CET) | 10:00 AM (EST) | 7:00 AM (PST)
🌍 Let’s reshape the future of biopharma together! Register now to secure your spot:
https://event.on24.com/wcc/r/4833582/9685C4675960B12EA5CC9FD88D7DFC2B
